RxDoctor Payments Data

Kimberly Stepien, MD

Ophthalmology · Madison, WINPI 1497709174

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Genentech, Inc.. That places this record below the midpoint for ophthalmology clinicians in WI, where the typical reported total is $301.

$51in general payments, 2019–2025

Across 1 payment — averaging $51.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$51
$445,613in research payments, 2019–2025

Across 21 payments — averaging $21,220 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$446K

What the payments were for

  • Food & beverage$51100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.1$51

How this compares

$51 in reported general payments places this provider in the 25th percentile of 337 ophthalmology providers in Wisconsin.

See all ophthalmology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$108,741
Medicare patients
320
Services billed
2,191

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Timolol Maleate12$51

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →